- TRADE NAMES: Bezalip (Roche); Bezamidin; Cedur; Nimus; Oralipin
- INDICATIONS: Hypercholesterolemia, hyperlipidemia, Type II diabetes
- CLASS: Antilipemic, Fibrate
- HALF-LIFE: 1–2 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cholestyramine, Cyclosporine, HMG-CoA reductase inhibitors, MAO inhibitors, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 02/16/2024
